Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Post by 1stRuleon May 08, 2015 10:25pm
189 Views
Post# 23710775

Anyone who's been in this for more than a few months

Anyone who's been in this for more than a few monthsshould be a really happy camper!  As recently as Feb this was sitting in the teens and low .20s, and is now typically in the .40s, and .50s... even with minimal news and revenue not expected for another month or so.  EXACTLY as expected months ago. 

Hate seeing people slam the longs on Vanc.  I've been in and out once already (in in the .20s-.30s and out at .70 near the end of the last spike.  I made decent money on it, and it's posts from the longs that got me looking at it initially.  I've got a bit in it again now, and will likely get more if some of my others do well.  Yes, it's bounced a few times on spec, welcome to the venture!  But don't slam people because you're not making as much as quickly as you'd hoped.  This is all speculation until revenue starts coming in, and, if it does even marginally as well as expected, could result in a huge profit, regardless of if you bought in at .42 or .94.

Unless your track record is perfect, and you're providing excellent advice every time you open your mouth, don't slam others.  And hell... even if you ARE perfect, you still have a responsibility to do your own DD before you buy something.  If you're always buying based strictly on what someone you don't know on the Internet says... well...

Do your own DD, GL and GN
Bullboard Posts